Navigation Links
Medivation Announces Participation in Upcoming Conferences
Date:8/28/2008

SAN FRANCISCO, Aug. 28 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the following conferences:

-- BioCentury's NewsMakers in the Biotech Industry on Thursday, September 4, at 9:00 a.m. Eastern Time at the Millennium Broadway Hotel & Conference Center

-- 2008 UBS Global Life Sciences Conference on Wednesday, September 24, at 4:30 p.m. Eastern Time at the Grand Hyatt New York

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

A live audio webcast of each presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
8. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...to postmenopause , , MONTVALE, N.J., Dec. 2...nsity of vasomotor symptoms is a challenge for wom...he Journal of Family Practice have recently publi...ging the transition from perimenopause to postmeno... and Lee P. Shulman, MD, discuss the benefits of h...
(Date:12/2/2008)... -- eResearchTechnology, Inc.,(eRT), (Nasdaq: E...Clinical,technology, ePRO and other services to t...and related industries, announced today that Dr. M...hief Executive Officer, and Keith,Schneck, the Co...present at,the Piper Jaffray Health Care Conferen...
(Date:12/2/2008)...ted Cardiovascular Associates,(ACC), a 38-doctor ...tions in,Southern New Jersey, today announced tha...lth records and Sage Intergy practice management s...ich cares for more than 30,000 patients,annually,...ion to enhance care,delivery, clinical trial rese...
(Date:12/2/2008)...stCall/ -- Tianyin,Pharmaceutical, Co., Inc., (NY... modernized traditional Chinese medicine ("TCM") b...mentation of a new sales and marketing strategy to...s into three classes in order,to optimize their s...ategy has classified distributors into three class...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3
...is . - A Green Bay soil-technology company that us...products to market has won the 2006 Governor,s Sma...00 prize that comes with it. , , ENCAP, LLC , whi...nology products, was presented the award during th...ymposium presented by the Wisconsin Technology C...
...is. - CDW Corp. , the Illinois-based technology ...n Networks , is elevating a top salesman to handle...pany has put vice president of sales Steven Schuld...hnology solutions provider, into CDW. , ,CDW, head...ately-held Berbee on Oct. 11 for approximately $18...
...is. - Mirus Bio Corp. , a Madison-based biotechn... outside the U.S., that covers a method of treatin...ith an injection of genes. , ,The patent, titled "...method for delivering a wide range of therapeutic ... and compliments a patent already obtained in the ...
...is. -You,re in an elevator next to a venture capi...but doesn,t know the first thing about it yet. , ...That,s the premise of the Elevator Pitch Olympics,...osium . This year, a panel of eight investors dish...repreneurs who presented their businesses in front...
Other Biology Technology:Green Bay's ENCAP wins tech transfer award 2Mirus granted European patent for gene therapy 29 tips for making 90 seconds count in an investment pitch 2
(Date:12/1/2008)...vailable at the online site of the journal Biolog...orts for the first time that vitamin D induces imm...production of the antimicrobial protein cathelicid... trophoblast cells to the active form of vitamin D...reased antibacterial response in the trophoblast c...
(Date:12/1/2008)... The Missouri Botanical Garden Press (MBG Press) ...the species of vascular plants for the Southern Co.... Catlogo de las Plantas Vasculares del Cono Sur (... taxonomic checklist of the plants of Argentina, s...database is essentially a dictionary to the names ...
(Date:12/1/2008)..., R.I. [Brown University] Gray mold is a gardener...ific name Botrytis cinerea , is a scourge to more...s, including staples such as tomatoes, strawberrie...e, peas, peppers, and potatoes. Gray mold envelops...hat poisons the host plants, cells, eventually cau...
(Date:12/1/2008).... In the race for bioengineered crops, sequencing... multi-leg relay. Once the sequence is complete, t...ify genes, functions. A draft sequence of the soyb...me will be available soon. Taking the next step in...nary Plant Group researchers have demonstrated the...
Breaking Biology News(10 mins):Missouri Botanical Garden publishes first catalogue of plants of the Southern Cone 2Brown chemist finds gray mold's killer gene 2Tool helps identify gene function in soybeans 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 1Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 2Warburg Pincus Acquires 5 4 25 of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank 6535 3Nets Star Josh Boone Kicks Off Free Summer Meals Program 23965 1Warfarin Safer Than Heparin for Some Strokes 23963 1Warfarin Safer Than Heparin for Some Strokes 23963 2Closing coal burning power plant in China and improved cognitive development in children 23959 1Closing coal burning power plant in China and improved cognitive development in children 23959 2Closing coal burning power plant in China and improved cognitive development in children 23959 3
...ogists at the University at Buffalo have shown for...ing antifungal agent in saliva, kills the oral pat... most HIV-related oral infections. , Researchers ...at histatin binds to a specific membrane protein c...rough the cell membrane of the pathogenic fungus C...
...tients may one day benefit from treatment with mix...ed recently in the Proceedings of the National Aca...te scientists have demonstrated how the right comb...cell,s communication network, ultimately demobiliz...research led to the identification of a family of ...
...and Drug Administration (FDA) today announced a se...ing of the non-steroidal anti-inflammatory class o...n and non-prescription (over-the-counter (OTC)) no...ducts is available on the Internet at http://www.f...ay,s actions protect and advance the health of the...
... of a new technique to map connections among nerve...Center scientist dreaming of solving the mysteries... mouse brain stimulate others, researchers in Japa...on responsible for keeping animals awake receives ... sleep, as well as reinforcing, positive signals f...
Other Biology News:Discovery may lead to better Candidiasis drug 2Two are better than one 2FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Brain-mapping technique aids understanding of sleep, wakefulness 2Brain-mapping technique aids understanding of sleep, wakefulness 3
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C
TUP1 Market Segment: Molecular Biology
UbcH7 interacts with the HECT protein, E6-AP and the c-Cbl RING domain. Evidence suggests that this E2 is involved in both the degradation of non-""N-end rule"" protein substrates and of certain N-a
COMING SOON: Anti-Mouse C5a Receptor (CD88), Clone 10/92 Monoclonal Antibody
Biology Products: